ZENI: Record Q1 revenue and UK contracts drive Zenicor's return to profitability

About this update from Zenicor Medical Systems Ab

Zenicor posted record Q1 revenue and returned to profitability, driven by UK expansion and strong demand for arrhythmia diagnostics. Cash flow remains a challenge, but ongoing contracts and studies support long-term growth prospects.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Zenicor Medical Systems Ab